Apex Healthcare Berhad

 
  DOWNLOAD ANNUAL REPORT
  FINANCIAL RESULTS
 

Board of Directors


DIRECTORS’ INFORMATION
    Leong Khai Cheong
Senior Independent
Non-Executive Director

 
 
 
Dr Kee
Dr Kee Kirk Chin, 54, a Singaporean, was appointed to the Board on 15th February 2000, as the Managing Director of the Company on 3rd March 2000 and became Chairman and Chief Executive Officer on 19th May 2010. He obtained a Bachelor in Arts with Honours in 1985, a Bachelor of Medicine & Bachelor of Surgery in 1987 and a Master of Arts in 1989 from University of Cambridge, UK and a Master of Business Administration (MBA) with distinction in 1993 from University of Hull, UK. He is a registered Medical Practitioner with the Singapore Medical Council and the General Medical Council, UK. He began his career as a House Officer with National University Hospital, later joining United MediCorp Pte Ltd as Director of Business Development in 1990, becoming its Chief Executive Officer in 1996. United MediCorp had interests in several healthcare companies in six Asian countries involved in pharmaceuticals, clinical equipment, hospital support services and private hospitals. He was appointed to the Board of Singapore Corporation of Rehabilitative Enterprises on 4th April 2010 and is the Chairman of its Audit and Risk Management Committee.

He is the son of Kee Tah Peng @ Hee Teck Peng. He is deemed to be a substantial shareholder of the Company as he is a substantial shareholder and Director of Apex Pharmacy Holdings Sdn Bhd, which holds 40.6% equity in the Company. He does not have any other family relationships with any other director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2015 and has had no convictions for any offences within the past 10 years.
 
Go to Top
 
 
Robert Dobson Millner
Robert Dobson Millner, 65, an Australian, was appointed as a Non-Independent Non-Executive Director of the Company on 23rd February 2000. He is currently a member of the Nomination Committee. He was re-designated as a member of the Remuneration Committee on 19th August 2015. He was a farmer and grazier prior to joining the Board of Washington H Soul Pattinson & Co Limited (“WHSP”) in 1984, a company listed on the Australian Stock Exchange with principal activities in properties, coal mining, bulk handling, manufacturing, wholesaling and retailing of pharmaceutical products, and reconstitution and extrusion of polyethylene.  He was appointed Deputy Chairman of WHSP in 1997, becoming its Chairman in 1998. He is also the Chairman of Brickworks Limited, Milton Corporation Limited, New Hope Corporation Limited, and Director on the Boards of Australian Pharmaceutical Industries Limited and TPG Telecom, all of which are companies listed on the Australian Stock Exchange. He is a member of the Institute of Company Directors, New South Wales, Australia and a fellow of the Australian Institute of Directors.

He is the Chairman of WHSP, which holds 30.3% equity in the Company. He does not have any family relationship with any other director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2015 and has had no convictions for any offences within the past 10 years.
   
Go to Top
   
 
Leong Khai Cheong
Leong Khai Cheong, 64, a Malaysian, was appointed as an Independent Non-Executive Director of the Company on 18th February 2000 and as Senior Independent Non-Executive Director on 24th August 2005. He was appointed as Chairman of the Nomination Committee and re-designated as a member of the Audit Committee on 19th August 2015. He has relinquished his position as member of the Remuneration Committee with effect from 19th August 2015. He is a Fellow of the Association of Chartered Certified Accountants, UK, a Certified Public Accountant, Singapore, as well as a member of the Malaysian Institute of Accountants. He holds associate membership of the Chartered Institute of Management Accountants and the Institute of Chartered Secretaries and Administrators. He held various senior positions in George Kent (M) Bhd and United Engineers Limited, which are companies listed on the Stock Exchanges of Malaysia and Singapore respectively. He is currently a Director of a private Malaysian company involved in the manufacture and assembly of engineering and other equipment and provision of engineering services for the water industries.

He does not have any family relationship with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2015. He has had no convictions for any offences within the past 10 years.
   
  Go to Top
   
 
Datuk Noharuddin Bin Nordin @ Harun
Datuk Noharuddin Bin Nordin @ Harun, 60, a Malaysian, was appointed as Independent Non-Executive Director of the Company on 20th May 2015. He was appointed as a member of the Audit Committee on 19th August 2015. He graduated with a Master of Business Administration from the University of Birmingham, UK in 1992. He has vast working experience with the Ministry of International Trade and Industry (“MITI”), Malaysia External Trade Development Corporation (“MATRADE”) and Malaysian Investment Development Authority (“MIDA”).  He was the Assistant Director of MITI from 1986 to 1993. He joined MATRADE in 2000 and he was the Chief Executive Officer of MATRADE from 2006 to 2011. He was the Chief Executive Officer of MIDA from 2011 until his retirement in February 2014. He is currently Independent Director and Chairman of the Audit Committee of Malaysia Venture Capital Management Berhad, and also a Director of Kulim Technology Park Corporation Sdn Bhd.

He does not have any family relationship with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all three Board Meetings held in the financial year ended 31st December 2015 since his date of appointment and has had no convictions for any offences within the past 10 years
   
  Go to Top
   
 
Mae Heng
Heng Su-Ling Mae, 45, a Singaporean, was appointed as Independent Non-Executive Director of the Company on 20th November 2008 and is a member of the Remuneration Committee. She was appointed as Chairman of the Audit Committee and ceased from office as Chairman of the Nomination Committee on 19th August 2015. She graduated with a Bachelor of Accountancy from Nanyang Technological University, Singapore in 1991 and is a Chartered Accountant with the Institute of Singapore Chartered Accountants (ISCA). She has over 16 years of experience in an audit, corporate finance and business advisory environment with Ernst and Young, Singapore. In senior management positions, her audit portfolio included several Singapore publicly listed companies, multinational companies and private companies of various sizes and industries operating globally. She was appointed an Independent Non-Executive Director of Ossia International Ltd on 27th April 2010 and also Chairman of its Remuneration Committee. She was also appointed an Independent Non-Executive Director and Chairman of the Audit and Remuneration Committees of Asiatravel.com Holdings Limited on 27th April 2012. Both companies are listed on the Singapore Exchange.

She does not have any family relationship with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. She attended all of the four Board Meetings held in the financial year ended 31st December 2015 and has had no convictions for any offences within the past 10 years.
   
  Go to Top
   
 
Jackson Chevalier Yap-Kit-Siong
Jackson Chevalier Yap-Kit-Siong, 64, a Singaporean, was appointed as a Non-Independent Non-Executive Director of the Company on 15th February 2000. He was re-designated as an Independent Non-Executive Director on 25th February 2015. He was appointed as Chairman of the Remuneration Committee on 19th August 2015. He graduated with a Bachelor of Engineering with Honours from University of Auckland, New Zealand in 1974 under a Colombo Plan Scholarship. He worked in various technical and management positions in the oil and gas sector with several multinational corporations before joining United Engineers Limited (“UEL”) as Chief Operating Officer and later, Group Managing Director and Director of UEL, a company listed on the Singapore Stock Exchange, whose principal activities are in the construction and engineering of buildings, properties and environmental projects. He retired in January 2014 as CEO and from the UEL Board in April 2014. On 29th January 2015, he was appointed as an independent director of Singapore listed UE E&C Ltd.

He was a director of Apex Pharmacy Holdings Sdn Bhd, which was holding 40.5% equity in the Company until 18th March 2014. Save as disclosed above, he does not have any other family relationships with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2015 and has had no convictions for any offences within the past 10 years.

   
  Go to Top
   
 
Dr Ahmad Kamal
Tong Yew Sum, 73, a Malaysian, was appointed as Independent Non-Executive Director of the Company on 21st May 2014. He was appointed as a member of the Nomination Committee and has relinquished his position as member of the Audit Committee with effect from 19th August 2015. He graduated with a Bachelor of Pharmacy from the University of Singapore in 1964, joining the Apex Pharmacy Group in 1965 as a pharmacist. He held various senior positions in the Group, involving primarily in retail, marketing and distribution activities, and retiring in 2005. He was the Executive Director of Malaysian Organisation of Pharmaceutical Industries from 2007 to 2014 and also its past President. He was formerly an adjunct lecturer at the Pharmacy Faculty of the University of Malaya, council member of the Malaysian Pharmaceutical Society and a current member of the Pharmacy Board of Malaysia.

He does not have any family relationship with any director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He attended all of the four Board Meetings held in the financial year ended 31st December 2015 and has had no convictions for any offences within the past 10 years.
   
  Go to Top
   
 
Dr Ahmad Kamal
Kee Kirk Chuen, 50, a Singaporean, was appointed to the Board on 18th May 2016 as Non-Executive Non-Independent Director. He obtained a Bachelor of Science (Electrical Engineering) in 1986, a Master of Engineering (M. Eng) in 1989 and a Master of Business Administration (MBA) in 1996 from Cornell University, USA. He was the Executive Director of Apex Pharmacy International Pte Ltd from 1989 to 2004. From 2005 to 2007, he was a deputy director at the National Council of Social Service, Singapore, and a director of Apex Holdings Pte Ltd since 2007. In 2010, he was appointed Deputy General Manager and in 2016, the Deputy Chief Executive of Temasek Foundation Cares CLG Limited, a Singapore non-profit philanthropic organisation established to improve the lives of underprivileged individuals, families, and communities in Singapore.

He is the brother of Dr Kee Kirk Chin. He is deemed to be a substantial shareholder of the Company as he is a substantial shareholder and Alternate Director (to Mr Kee Tah Peng) of Apex Pharmacy Holdings Sdn Bhd, which holds 40.6% equity in the Company. He does not have any other family relationships with any other director and/or major shareholder of the Group, nor any personal interest in any business arrangement involving the Company. He has had no convictions for any offences within the past 10 years.
 
   
  Go to Top